Amphastar Pharmaceuticals, Inc. Company Profile
Amphastar Pharmaceuticals, Inc. as SEC EDGAR records it: incorporation, addresses, industry, fiscal year end, filer category and former names.
- Country of operation (business address): Value United States.
- Business address: Value 11570 SIXTH STREET, RANCHO CUCAMONGA, California, 91730, United States.
- Mailing address: Value 11570 SIXTH STREET, RANCHO CUCAMONGA, California, 91730, United States.
- Industry (SIC): Value 2834 Pharmaceutical Preparations.
| Measure | Value |
|---|---|
| Country of operation (business address) | United States |
| Business address | 11570 SIXTH STREET, RANCHO CUCAMONGA, California, 91730, United States |
| Mailing address | 11570 SIXTH STREET, RANCHO CUCAMONGA, California, 91730, United States |
| Industry (SIC) | 2834 Pharmaceutical Preparations |
| Fiscal year end | 12-31 |
| Filer category | Large accelerated filer |
| Listed stock (Section 12(b)) | Common Stock, par value $0.0001 per share · AMPH · NASDAQ 10-Q filed 2026-08-06 cover |
| Shell company | No 10-Q filed 2026-08-06 cover |
| Smaller reporting company | No 10-Q filed 2026-08-06 cover |
| Emerging growth company | No 10-Q filed 2026-08-06 cover |
| Current in its reporting | Yes 10-Q filed 2026-08-06 cover |
| Well-known seasoned issuer | Yes 10-K filed 2026-02-26 cover |
| Voluntary filer | No 10-K filed 2026-02-26 cover |
| First EDGAR filing | 2005-02-11 (S-1) |
| SEC CIK | 1297184 |
| EIN | 330702205 |
| Phone | 909-980-9484 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |